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For much of the history of toxicology, the sensitivity of the developing organism to chemical
perturbation attracted limited attention. Several tragic episodes and new insights finally taught us
that the course of early brain development incurs unique risks. Although the process is exquisitely
controlled, its lability renders it highly susceptible to damage from environmental chemicals. Such
disturbances, as recognized by current testing protocols and legislation such as the Food Quality
Protection Act, can result in outcomes ranging from death to malformations to functional
impairment. The latter are the most difficult to determine. First, they require a variety of measures
to assay their extent. Second, adult responses may prove an inadequate guide to the response of
the developing brain, which is part of the reason for proposing additional safety factors for children.
Third, neuropsychological tests are deployed in complex circumstances in which many factors,
including economic status, combine to produce a particular effect such as lowered intelligence
quotient score. Fourth, the magnitude of the effect, for most environmental exposure levels, may
be relatively small but extremely significant for public health. Fifth, changes in brain function occur
throughout life, and some consequences of early damage may not even emerge until advanced
age. Such factors need to be addressed in estimating the influence of a particular agent or group of
agents on brain development and its functional expression. It is especially important to consider
ways of dealing with multiple risks and their combinations in addition to the prevailing practice of
estimating risks in isolation. Key words: behavioral teratology, developmental toxicity, earnings,
Food Quality Protection Act, IQ, multiple risks, Parkinson's disease, pesticides, social environment.
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Near the beginning ofour just-expired cen-
tury, the toxicology ofthat time was goaded
by pioneers like Harvey Wiley, whose persis-
tence and stubbornness helped create the
U.S. Food and Drug Administration (FDA).
Wiley became the first FDA Commissioner
in 1907, but he had earlier become gravely
troubled by the adulteration of foods by
unscrupulous or ignorant producers. While
chief chemist of the U.S. Department of
Agriculture, he recruited what became known
as the "Poison Squad," a group ofyoung men
who consumed food treated with various
chemicals to determine ifthey might experi-
ence adverse reactions including depression,
headaches, and even more severe symptoms.
Photographs taken around 1905 show them
seated at dining tables, wearing coats and ties,
as they valiantly consumed their tainted diets.
Informed consent was not an issue at the time
but probably would not have dissuaded
Wiley's acolytes. They considered themselves
public servants, an intriguing distinction with
the current practice and ethical quandaries of
paying volunteers to consume pesticides so as
to change acceptable exposure standards.
Healthy young men would have been a
judicious choice for poison squad subjects
because, ifthey proved sensitive, Wiley could
argue that less robust individuals might more
easily succumb. There are no reports to indi-
cate that he did so. In fact, the question of
children as special targets offood additives,
environmental poisons, and even drugs
apparently arose much later. A distinctive
label for prenatal ethanol toxicity, Fetal
Alcohol Syndrome, did not appear until the
1970s (1) despite centuries of anecdotal
observations. The contemporary discipline of
teratology is largely a product ofthe shoddy
behavior ofthe company that concealed the
horrors ofthalidomide, which had been mar-
keted as a safe effective sedative during preg-
nancy. Aworldwide epidemic ofbirth defects
began to emerge during the 1950s and early
1960s in the babies ofwomen who had been
prescribed thalidomide. The German firm,
Chemie Griunenthal that had manufactured
and marketed thalidomide kept such reports
secret until the evidence became overwhelm-
ing, but, by that time, the drug had claimed
thousands ofvictims.
The United States was spared this tragedy
because ofthe stubbornness ofFrances Kelsey,
who received the President's Award for
Distinguished Federal Civilian Service in
1962 for denying FDA approval ofthalido-
mide. The Kefauver-Harris amendments that
same year to the Food, Drug and Cosmetic
Act (2), which had last been amended in
1938, were enacted in response to the thalido-
mide crisis. The amendments added a require-
ment for proofofeffectiveness for drugs, and
also required manufacturers to send reports of
adverse drug reactions to the FDA.
Even after the thalidomide incident, the
full dimensions of developmental toxicity
remained unappreciated. The ancient metals,
mercury and lead, exemplify how little recog-
nition, until quite recently, was accorded the
special vulnerabilities ofchildren. Needleman
(3) has related the lead story on many occa-
sions, noting the recognition oflead poison-
ing in workers at the same time that the
effects on child development escaped notice.
The mercury story is equally baffling in its
exclusion of children. Mercury was recog-
nized as a poison even in antiquity. Its neuro-
toxic properties, in the form of mercury
vapor, received labels such as "hatter's
shakes," which described its propensity to
induce excessive tremor, and "erethism," a
collection ofpsychological disorders manifest-
ing features such as being hyperirritable;
blushing easily; having a labile temperament;
avoiding friends and/or public places; being
timid and/or shy; being depressed and/or
despondent; suffering from insomnia; and
suffering from fatigue.
Mercury as a potential developmental
toxicant received no attention. The childhood
affliction of Pink Disease, or acrodynia,
which had been discussed in the medical liter-
ature earlier in the century, was typically
ascribed to infectious disease. Its symptoms
did not coincide at all with those expressed by
adults who had been poisoned by mercury.
Pink disease symptoms included: apathy and
irritability; rashes and sloughing of skin;
reddening ofcheeks and nose; cold blue fin-
gertips and toes; profuse sweating and hyper-
tension; itching and/or burning sensation;
photophobia and anorexia; hypotonicity and
tremor; pain in extremities and paresthesias;
and muscle twitches.
Not until 1947 was Pink Disease linked
to mercury. Mercury appeared mostly in the
form ofcalomel (mercurous chloride), which
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was widely used in teething powders (4).
Once calomel was removed from teething
powders, the incidence ofPink Disease plum-
meted. Now, Pink Disease is largely a prod-
uct ofexposure to mercury vapor, which is
still pervasive in the environment. Older latex
paints, which contained a phenylmercury as a
fungicide, emitted mercury vapor after appli-
cation; jewelry factories used elemental mer-
cury to produce gold amalgams and literally
left pools of it behind in sites they aban-
doned; fluorescent bulbs contain mercury in
the ballast assemblies; some religious groups
use elemental mercury in their ceremonies;
and certain ethnic groups use mercury com-
pounds in cosmetics such as skin lighteners.
The Current Scene
Testing for developmental toxicity has
become a fundamental component ofsafety
assessment for environmental chemicals. It
encompasses the end points offetal death,
malformations, altered growth, and the much
broader question offunctional abnormalities.
This last criterion is the most difficult to
determine. It embraces a vast arrayofpossibil-
ities, most ofwhich are themselves comprised
ofmultiple indices; learningdeficits, for exam-
ple, describe a class ofproblems rather than a
single problem. They may emerge clearlylong
beyond gestation and only in specific settings
such as the classroom. Functional measures
are typically affected by lower exposure levels
than other end points relied on as indices of
developmental neurotoxicity.
FetalAlcohol Syndrome offers an example
ofthe progression from an emphasis on struc-
ture to an emphasis on function (1). In its
original formulation, it featured craniofacial
dysmorphologies. With further investigation
focused on the effects of lower levels of
maternal alcohol intake than those evoking
structural defects, a new syndrome, labeled
Fetal Alcohol Effects, emerged. Now known
as Alcohol-Related Neurodevelopmental
Disorder, it is applied to patients who display
behavioral or cognitive abnormalities such as
learningdifficulties.
The special status offunctional disorders
inspired the term and discipline ofbehavioral
teratology. Behavioral teratology describes
functional abnormalities induced by prenatal
exposures rather than the structural deficits
assayed by teratologists. That identification
has taken on aquasi-official status. Regulatory
bodies around the world have come to recog-
nize the importance oftesting for functional
abnormalities produced by pharmaceuticals,
spurred by data that indicate the remarkable
scope ofdrugs capable ofleaving a residue of
behavioral problems (5). These types of
drugs include: vitamin analogs, cytostatics,
gastrointestinals, hyperlipemics, bronchiolyt-
ics, spasmolytics, analgesics, antiallergens,
antibiotics, cardiovasculars, anticoagulants,
and anticonvulsants.
The FDA lags behind its counterparts in
Great Britain, France, and Japan in recogniz-
ing neurobehavioral assays as an essential
aspect ofdrug testing. One example ofhow
the FDA sometimes discounts neurobehav-
ioral toxicity in children is seen in its require-
ments for the safety testing offood additives.
Despite a string ofpublications since the late
1970s showing that some children respond
adversely to additives, especially food dyes, at
levels prevailing in the diet, the agency persists
in its claim that "... well-controlled studies ...
have produced no evidence that food color
additives cause hyperactivity or learning dis-
abilities in children" (6). Such a statement dis-
regards reports based on controlled clinical
trials (7-9) and lacks familiarity with the kind
of careful statistical analysis required to
identifysusceptible subpopulations (10).
For most potentially toxic chemicals, we
possess only animal, typically rodent, data.
To provide an adequate margin ofsafety for
humans, current practice first examines the
dose-response function to select a dose statis-
tically indistinguishable from the control
preparation [the no-observed-effect level
(NOEL)]. If the NOEL is derived from a
chronic exposure study, it then divides this
dose by a safety or uncertainty factor of 100
to calculate a reference dose or allowable daily
intake: a factor of 10 to account for species
differences and a factor of 10 to account for
variations in sensitivity among individuals.
Currently, for food additive toxicity testing,
the FDA requires manufacturers to fulfill an
extensive set ofprotocols, including teratolog-
ical evaluations, in rodents. It then applies the
100-fold safety factor. Neurobehavioral test-
ing is not required. The difference between
what the literature shows in children and
allowable daily intakes based on traditional
protocols is highlighted in Table 1. The levels
offood colors eliciting behavioral responses in
children are 50-60 times less than the con-
ventional exposure standard.
Table 1. Comparison offood dye doses(in milligrams).
Weiss Nutrition
Color et al.a Foundationb ADIc
Bluel 0.80 0.85 300
Blue 2 0.15 0.46 37
Red 3 0.57 1.66 150
Green 3 0.11 0.04 150
Red 40 13.80 10.45 420
Yellow 5 9.07 7.34 300
Yellow 6 10.70 6.20 300
ADI, allowable daily intake.
aln a challenge experiment in which they elicited acute behav-
ioral responses in young children 17). bEstimated intakes in chil-
dren calculated by the Nutrition Foundation and used in several
challenge studies (11). CADI derived from animal testing and
based on NOELs divided by a safety factorof 100(12. The doses
eliciting behavioral responses in children are many times lower
than the ADI, which is not based on neurobehavioral testing.
Pesticides and the Food
Quality Protection Act
One major outcome of our recognition that
developing organisms may be uniquely vul-
nerable to chemical challenge is the Food
Quality Protection Act (FQPA) of 1996 (13).
It may be viewed as the second stage ofthe
National Academy of Sciences report (14)
that noted the enhanced health risks arising
from the combination ofdevelopmental sus-
ceptibility and the higher relative intakes of
pesticides by children. The FQPA embodied
the following risk assessment issues: inclusion
of an extra 10-fold safety factor for children,
in utero exposures, cumulative effects of pesti-
cides and substances with a common mode of
action, aggregate exposure (e.g., food and
water), and endocrine disruption.
The most controversial feature of the
FQPA specifies, at the discretion ofthe U.S.
Environmental Protection Agency (EPA), an
additional 10-fold safety factor for calculating
acceptable intakes for children. This attribute
ofthe FQPA has prompted objections among
many elements of the pesticide industry
because it can sharply restrict sales of many
products whose residues appear in foods.
The other entries in the list arise from the
same apprehensions that prompted the added
safety factor. In utero exposures are required
because, for so many agents, as recognized by
current pesticide regulations, fetal develop-
ment is an exceedingly sensitive stage ofthe
life cycle, offering the prospect oflatent dam-
age whose consequences will surface later in
life. The reference to cumulative effects
acknowledges that different products may act
in similar ways, especially ifthey come from
the same chemical class; individual chemical
exposure levels may fallwithin regulatory lim-
its but prove toxic in the aggregate.
Moreover, even chemicals from different
classes may still share the same mechanisms of
toxicity or be measured by equivalent end
points; for example, both lead and polychlori-
nated biphenyls (PCBs) can reduce intelli-
gence quotient (IQ) scores. Similarly,
exposure may come from different sources
such as produce residues, pesticide deposits in
areas such as schoolyards where children play,
contaminated drinking water, and residential
surfaces. It makes little sense to treat stan-
dards for each source separately.
The FQPA (13) also included language
directed at the question ofendocrine disrup-
tion. We have come to recognize that many
chemicals in the environment, including those
found in nature, can exert powerful effects on
hormone action, particularly on the role hor-
mones play in early development. In response
to FQPA concerns, the EPA created the
Endocrine Disruptor Screening and Testing
Advisory Committee (EDSTAC) to design a
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screening and testing strategy to determine
how to select chemicals for screening, how to
choose the assays included in a screening bat-
tery, and the circumstances under which
chemicals should be subjected to further test-
ing. EDSTAC's targets are primarily estro-
genic chemicals, however. A number of
pesticides act as androgen antagonists and, in
rats exposed in utero, induce signs offeminiza-
tion, such as prominent nipples, in males
(15). Testing for antithyroid properties is also
not projected, although such agents may pose
an even greater developmental hazard than
estrogenic chemicals because of the high
prevalence ofiodine deficiency.
Safety Factors for Children
Two opposing viewpoints have clashed over
the added 10-fold safety factor. Industry
groups contend that current testing guidelines
already include provisions aimed at develop-
mental exposures such as two-generation
studies. Their challengers argue that the pro-
visions are insufficient to protect children.
These latter groups base their argument partly
on the lack ofinformation about variations in
dietary practices, inadequate monitoring of
residues, and other gaps in knowledge. But
the strongest argument for the additional pro-
tection is what might be called the ecology,
particularly the spatial ecology, ofchildhood.
These include such factors as activity altitude
(young children spend much time on floors;
they stir up and breathe dust and residues;
and exposure to dust may be 10 times greater
than adults); proportionality (children con-
sume relatively more juice, fruit, and water
than adults); exploratory behavior (young
children literally lead a hand-to-mouth exis-
tence); and breast milk (lipid-soluble agents
can be transmitted in quantity).
Children occupy a distinctive ecological
niche in a world tuned to adults. Size is
important because ofwhat might be termed
the altitude factor. Children's activities take
place close to ground level. Dense vapors such
as mercury collect at much higher concentra-
tions near the floor than at adult waist level.
The same would be true for any volatile mate-
rials that are denser than air. With their activi-
ties, children also stir up floor dust that they
then inhale. One reason that farm families
and agricultural communities typically experi-
ence greater pesticide exposures than the bulk
ofurban dwellers (16-18) is inadvertent depo-
sition in the home through air currents, foot
traffic, and contaminated clothing. In some
cities, as in the upper west side ofManhattan,
New York, pesticide use also can be heavy
because ofattempts to eliminate vermin (19).
Lead in household dust is an example ofa pre-
viously neglected exposure source that is sig-
nificantly correlated with blood levels in the
children (20). One frequent concomitant of
child exploration, hand-to-mouth sampling, is
another exposure source that is poorly quanti-
fied. A recent survey and analysis (21) indi-
cates that a small percentage ofchildren may
ingest much greater quantities ofsoil than the
EPA standard of200 mg/day.
Finally, breast milk, despite its great advan-
tages, is also an efficient medium for transfer-
ring lipid-soluble chemicals from mothers to
infants. All ofthese exposure sources demon-
strate the futility oftrying to characterize risk
by reliance on a deductive sequence stretching
from NOELs, to reference doses, to residue
levels. The stipulations ofthe FQPA represent
only the prelude to the more global, compre-
hensive analysis of exposure required for a
detailed accurate assessment ofrisk.
Even an additional safety factor for chil-
dren fails to take account ofexposure spikes
that may be experienced by many children.
Developmental data from humans consist
almost entirely ofpoisoning cases, probably a
result ofthe fact that most calls to poison con-
trol centers about pesticides involve children.
In Minnesota in 1988, pesticide poisonings
accounted for 1,428 case files (22). The mean
case age was 5 years, and 50% ofall cases were
younger than 3 years of age. Insecticides in
residences were identified as the source in
most of the case files. In Toronto, Ontario,
Canada, the Hospital for Sick Children saw
1,026 cases ofpesticide poisoning in a single
year, 597 of which occurred in children
younger than 6 years ofage. These rates are
typical ofpoison control centers (23). Follow-
up observations are rare, unfortunately, even
for those cases that require medical interven-
tion. Children treated for poisoning by pesti-
cides such as lindane and diazinon were
observed by Angle et al. (24) to suffer appar-
ently persistent neurobehavioral problems.
Angle et al. (24) noted that "... there are no
long-term studies ofthe effects of poisonings
on children," and "... a provocative associa-
tion ... with later intellectual deficit . but
the intervening 30 years have seen no system-
atic attempts to explore these questions (25).
One exception to the dearth ofdevelopmental
data is the novel report (26) comparing two
agricultural communities in Mexico.
Residents came from the same ethnic stock,
but one community had adopted chemical-
based agriculture, whereas the other had
rejected it. Various indices ofneuropsycholog-
ical development suggested that children from
the traditional community proved superior on
several measures.
One other factor not explicitly acknowl-
edged by the FQPA is what we have learned
from agricultural workers. Evidence ofsubtle
neurobehavioral toxicity in adults, even at
clinically silent exposure levels (27-29) has
been accumulating steadily. Data verifying
lingering neurobehavioral deficits in adult
farmworkers after a clinically toxic exposure
(30-33) have also been accruing. Given the
pronounced vulnerability of the developing
brain to most neurotoxicants, we should
anticipate that children will display even
more pronounced responsiveness to the neu-
rotoxic properties of pesticides than adults.
The question might be framed in the form of
a pyramid, as depicted in Figure 1. Clinical
poisoning severe enough to necessitate med-
ical treatment occurs in a relatively small
number of children. Subclinical poisoning
detectable with neuropsychological testing
would reveal an even larger affected popula-
tion. Latent toxicity, also conceived of as
silent toxicity (34), may not become apparent
until additional challenges to function, such
as the demands of the classroom, supervene.
Another is aging.
Many investigators have suggested that
the roots ofsome neurodegenerative diseases
may be found in events that occurred during
early development (35). These authors
proposed that
... Alzheimer's disease, Parkinson's disease
(PD), and motoneurone disease are due to
environmental damage to specific regions
of the central nervous system and that the
damage remains subclinical for several
decades but makes those affected especially
prone to the consequences ofage-related
neuronal attrition.
One source ofsupport for such suggestions is
the relationship between a history ofpesticide
exposure and PD. In some parts ofthe brain,
cell numbers dwindle with age. The change is
especially noticeable in the substantia nigra
(SN), an area in the subcortical collection of
nuclei known as the basal ganglia. The cells in
one region ofSN secrete the neurotransmitter
dopamine. Clinical signs of PD emerge when
most ofthese nerve cells die and can no longer
synthesize adequate supplies of dopamine.
Latent toxicity is one way of viewing the
Clinical pesticide
poisoning
Subclinical pesticide
Kpoisonlng
Latentpesticide
itoxicity
Figure 1. The toxicity pyramid for pesticides is designed
to show that, although only a small proportion of chil-
dren will manifest clear signs of excessive exposure,
many more will show effects detectable by neurobehav-
ioral testing, and even more will endure latent or silent
toxicity that only emerges with additional challenges
such as other pesticides, other environmental chemicals,
or other health problems.
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association between a history ofpesticide
exposure and an elevated risk ofPD (36). The
possibility ofsuch an environmental source
for PD is buttressed by the evidence (37)
showing no difference in concordance rates
for PD in monozygotic and dizogotic twins
60 years ofageandolder.
One possible explanation of the associa-
tion is an acceleration ofnatural cell loss in
SN induced by pesticide exposure, as shown
in Figure 2. It compares the rate modeled on
published data (38) with rates calculated on
the basis of additional accelerations of 0.1
and 0.3% annually. Even a rather small
acceleration of0.1% per year means that the
40% reduction in cell density that would
have occurred by the early 1970s is advanced
by about 10 years. It is hardly a negligible
shift and entails significant health and med-
ical consequences.
These consequences are depicted in Figure
3. The rate ofonset ofPD rises steeply with
age. The baseline curve plots representative
data from a U.S. urban community (39). The
other two curves show equivalent rates ofrise
but are displaced by 5 and 10 years, respec-
tively. At age 70 and above, the empirical
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Figure 2. Cell numbers decline with age in several
areas of the human brain. In the SN, the decline seems
to progress throughout life (38). Slight accelerations of
the process (0.1 and 0.3% per year) can foster the ear-
lier clinical emergence of PD. The arrows correspond to
a 40% loss, which some data suggest is a precursor of
clinical PD.
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Figure 3. Incidence of PD with age. Baseline data (39)
are compared to earlier hypothetical displacements of 5
and 10 years. Assume a baseline prevalence of about
0.012 at age 70 and above (39). In the year 2000, the
number of PD patients older than 70 years of age would
come to 309,672. Assuming the same prevalence at age
60, that is, displaced by 10 years, would bring the total
to 555,696. If the prevalence function were to be shifted
5years earlier, that number would be 424,728.
curve shows a prevalence of about 0.012.
Demographic projections based on that preva-
lence figure indicate that, in the year 2000,
the number ofPD patients above 70 years of
age would become 309,672. Ifthe prevalence
function were to be shifted by 10 years, the
total would come to 555,696.
The Social Environment as a
Dimension of Risk
Exposures to environmental chemicals repre-
sent only one dass ofrisks during child devel-
opment. Investigators have learned to be
highly sensitive to this problem, and when
they undertake to study risk factors in human
populations, neurotoxicologists typically obey
the conventions oftraditional epidemiology.
Ifan investigation targets a particular agent, it
attempts to strip away those influences that
might confound the effects ofthat agent in
isolation. This practice is essential to the
analysis ofdose-response relationships, to the
formulation ofexperimental hypotheses, to
the planning oflaboratory research, and to
the pursuit ofbiological mechanisms. The
virtues ofsuch a focused approach begin to
dissolve, however, when they have to be
translated into risk characterizations and pol-
icy implications. Neurotoxicant exposure and
its consequences for development are molded
into a larger environment from which they
cannot easily be extricated. The literature on
lead offers one illuminating example.
Lead research during the past 30 years has
mostly converged on behavioral development
in children. The predominant measure,
adopted because it is the one most easily
communicated, because it is the beneficiary of
an immense research effort extending over a
century, and because it summarizes a variety
offunctions, is IQ score. Often confused by
the public, and even by some scientists, with
an abstract quality termed "intelligence," it
remains useful because ofits correlations with
academic success, earnings, and even broader
criteria such as welfare dependency.
What is now a vast literature documents
an inverse relationship between indices oflead
exposure in children, such as blood level, and
IQ score. The relationship itself, as a simple
statistical measure, arouses relatively muted
debate. What does excitevigorous argument is
interpretation. The basis for argument in
neurobehavioral toxicology is the contribution
ofother variables. The contenders agree that
lead is only one component ofa multitude of
factors acting on IQ score. Maternal intelli-
gence, family income, parental intellectual
stimulation and care, maternal and paternal
education, race, marital status, maternal age,
extent ofprenatal care, maternal drug use
(alcohol, tobacco, and illicit drugs), maternal
psychopathology, and other aspects of the
child's history and environment also influence
IQscore. The strategy universally adopted by
serious investigators is to compensate statisti-
cally for these other influences, typically by
multiple regression procedures. Disagreements
arise over which confounders or control vari-
ables to include, and howto do so.
The practice ofisolating the contribution
ofa selected neurotoxicant is scientifically log-
ical but possibly misleading for public policy.
Stripping away potential confounders may
distort that contribution in a larger context,
partly because it can be carried to a point at
which it effectively eliminates lead exposure as
avariable (40). Given all we knowabout lead,
might it be time to proceed to larger ques-
tions? Should the old debates be put to rest?
Should we frame another kind ofquestion
and adopt another perspective? Should neuro-
toxicity be viewed as one element in a combi-
nation offactors acting jointly as a form of
risk vector? These questions are not novel.
They have been posed by others and in other
forms, as in the dilemma described by
Bellinger and Stiles (41). They discussed the
utility ofdifferent study populations in the
context oftheirown investigations as follows:
Other investigators chose to recruit their
samples from inner-city populations at far
higher risk ofdevelopmental handicap due
to a variety ofpoverty-related risk factors,
ofwhich lead is only one. The trade-offs
involved in this decision are that, on the
one hand, it may be difficult to reject the
possibility that any apparent lead-related
decrement in performance is not the result
ofresidual confounding (a potential Type
I error). On the other hand, it may be dif-
ficult to estimate, with adequate accuracy
and precision, any true lead-related decre-
ment amidst the "statistical noise" con-
tributed by correlated risk factors (a
potential Type II error) ...
Community attributes, beyond the form
ofcovariates, are one ofthe ways in which
customary measures ofneurobehavioral func-
tion may distort the total effect oftoxic expo-
sure. How the influence oflead on IQ scores
is evaluated provides one example. In his
meta-analysis oflead and IQ, Schwartz (42)
calculated that a 10-g/dL rise in blood lead
would produce a mean estimated loss of 1.85
IQpoints in a socially disadvantaged popula-
tion and a mean loss of2.89 IQ points in a
socially advantaged population. Such a dis-
crepancy might be used to argue that reduc-
tions in lead exposure might not be as
cost-effective in disadvantaged populations.
IQ Loss in Advantaged and
Disadvantaged Communities
Ifthe two populationswere to be compared by
broader criteria, the message might be differ-
ent. Figure 4 compares the effects ofshifts in
mean IQ in two different communities, one
Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000
I
378VULNERABILITY OF CHILDREN TO NEUROTOXIC HAZARDS
thatwould be ranked as advantaged and one as
disadvantaged. In many surveys, the differ-
ences in mean IQscores ofsuch populations
approximate about 15 points (43). Assume,
then, for modeling purposes, initial IQ distrib-
utions with respective means of 100 and 85,
both with standard deviations of 15. As an
impact index, calculate the number ofscores
below 70. Conventional education standards
tend to assume (despite the rise in scores over
several decades known as the Flynn effect) that
a score below 70 indicates the need for reme-
dial measures, and for some school systems,
signifies aclassification ofretarded.
With population sizes of 100,000 each, as
shown in Figure 4, a loss of 1 IQpoint in the
advantaged population increases the number
ofindividuals below 70 from 2,280 to 2,660.
In the disadvantaged population, the loss
assigns 17,530 rather than 15,870 individuals
to the below-70 category. Although the pro-
portional shift is greater in the advantaged
population (16.7%) than in the disadvantaged
population (10.5%), the number ofindividu-
als added to the developmentallydisabled cate-
gory is much larger in the disadvantaged
population (1,660) than in the advantaged
population (380). The discrepancies enlarge
with greater IQlosses, which could result from
higher neurotoxicant exposures. One result is
that expenditures arising from increased
demands for remedial education in the disad-
vantaged communitywould also greatlyexceed
those in theadvantaged community.
Figure 5 shows one perspective on the
multitude of stressors acting on disadvan-
taged communities. It depicts how an arrayof
challenges to optimal development, none of
which by itselfexerts a large effect, might
combine to create a pronounced depression
of functional potential as measured by IQ
score. For this conceptual model, the sizes of
the entries and their overlaps do not represent
actual data. The chart is designed only to
underscore the point that individual risk fac-
tors, none ofwhich alone might exert con-
spicuous influence, can jointly effect marked
changes in developmental potential. Joint
actions might take many forms; additivity is
one possibility, synergism is another.
Degraded intellectual potential is only one
facet ofhowenvironmental stressors can inter-
fere with neurobehavioral development. The
Rochester Longitudinal Study (43) followed a
cohort ofchildren, beginning at birth, to
ascertain the influence of maternal psy-
chopathology, primarily schizophrenia, on
developmental outcome. They included other
potential risk factors, as well, in their analyses
(Figure 6). The unexpected message from
their data led the authors to condude that the
number ofriskfactors, rather than anyspecific
factor, determined outcomes such as IQ and
social competence. Figure 6 depicts effects on
measures ofIQ and social-emotional compe-
tence at 4 years ofage. Individually, each risk
factor contributes a small amount ofthe total
variance averaging about 4%, about equiva-
lent to a 10-pig/dL increment on blood lead
level. Their cumulative effect, as shown in
Figure 6, can be dramatic.
Sameroffet al. (43) did not include neu-
rotoxicant exposure as a risk factor, although
some portion of their study population
inhabited housing with high levels oflead in
paint and dust (20). The trends depicted in
Figure 6 indicate that neurotoxicant exposure
might well exert a greater effect in combina-
tion with other risk factors ofthe type listed
in Figures 5 and 6 than in isolation. Figure 4
shows that the home and community envi-
ronment exert an enormous influence on the
outcomes ofneurotoxic exposures.
A second method to illustrate the way in
which different stressors, including toxic
exposures, might influence development is
shown in Figure 7. The uppermost curve
depicts the normal trajectory ofdevelopment.
Add exposure to a neurotoxic substance and
development proceeds at a lowered rate and
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Figure 4. Advantaged communities typically show about
a 15-point or 15% higher mean IQ score as compared to
disadvantaged communities. If both populations, as a
result of neurotoxic exposure, suffer an equivalent
decrease in mean IQ, the effect will be greater in the
disadvantaged community, as gauged by the number of
IQ scores below 70. A score below 70 is taken as evi-
dence of retardation and, in many school districts,
requires remedial education.
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Figure 5. Schematic model to show how individual com-
ponents of a stressful environment might cumulate to
reduce performance on IQ and othertests. The individual
stressors are shown as overlapping to suggest a lack of
independence, and their length is meant to indicate that
no single component is overwhelming in isolation.
reaches a lower asymptote. Add a second
stressor, low income (which, in practice,
would embody a collection ofstresses), and
rate and asymptote may fall even further.
Economic Implications of
Developmental Neurotoxicity
Impaired child development imposes
economic burdens on the entire society, not
solely on the individual. Behavioral difficulties
expressed in higher rates ofcrime and delin-
quency comprise one set ofoutcomes (44) but
are difficult to quantify in economic terms.
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Figure 6. Charts modified from a report on the
Rochester Longitudinal Study (43). Two end points are
shown for children tested at 4 years of age: (A) a rating
of social-emotional competence and(B) verbal IQ on the
Wechsler Preschool and Primary Scale of Intelligence
(WPPSI). Each individual risk factor accounted for about
4% (4 IQ points). The difference between the lowestand
highest riskchildren was approximately 30 IQ points or 2
SDs. Risk factors are maternal mental illness, high
maternal anxiety, rigid parental perspectives, few inter-
actions with infant, minimal maternal education,
unskilled occupation, disadvantaged minority, single
parenthood, stressful life events, and large family size.
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Figure 7. Schematic to show how the normal course of
development (intellectual attainment) might be slowed
by the addition of toxic exposures, poverty, and other
riskfactors. SES, socioeconomic status.
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Lowered IQ, as measured by standardized
tests, provides the best documented relation-
shipwith economic criteriasuch as earnings.
Much ofthe public, and even some scien-
tists, are confused about what IQscores mea-
sure. IQ tests are not used to gauge some
abstract quality called intelligence, but,
instead, constitute a sample ofperformance
with established predictive power. For exam-
ple, IQ scores are correlated with social class,
educational attainment, and income. The lat-
ter relationship facilitates one form ofeco-
nomic analysis of the costs arising from
environmental neurotoxicants. Such an analy-
sis should not be interpreted as a claim that
IQ determines earnings rather than as a
description ofan empirical relationship.
The relationship ofIQto income provides
a gauge by which to determine how much
societyloses by neglecting environmental con-
tamination. Salkever (45) has assembled the
most convincing calculations. They include
relationships among IQandyears ofschooling
and also take account of the cost of lost
income while in school and the discounted
value offuture earnings. By Salkever's calcula-
tions, in terms of 1995 dollars, each IQpoint
isworth $8,346 in lifetime earnings. Although
this sum is equivalent to only $200/year over
a working lifetime, it has to be viewed from a
population perspective. Ifenvironmental con-
tamination diminishes IQin the U.S. popula-
tion by an average of 1%, the annual cost
would come to $50 billion and the lifetime
costs to trillions. This sum is an underestimate
because a shift ofthe population mean to a
lower IQmeans more individuals thrust into a
score category below 70, which typically
mandates remedial education at a cost of
approximately $6,000 annually. Salkever's cal-
culation, ifitwere to indude this expenditure,
might raise the loss to the community ofone
IQpoint to as high as $10,000. Restrictions
on environmental pollution cost far less. In its
report to Congress on the Costs and Benefits
ofthe Clean Air Act (46), EPA investigators
estimated the direct costs ofimplementing the
act at $523 billion in 1990 dollars. Its esti-
mate of benefits during the same period,
mostly from the avoidance ofadverse health
effects, ranged from $5.6 to $49.4 trillion,
with a mean of$22.2 trillion. Based on these
calculations, the ratio of benefits to costs
ranges from 10.7 to 42. Those who oppose
restrictions on the environmental discharge of
chemical contaminants typically cite only the
estimated costs.
The tobacco settlement offers a com-
pelling example ofhow ignoring IQ losses
seriously underestimated the ultimate health
costs ofsmoking. The economic implications
ofdevelopmental impairment due to mater-
nal smoking are based on a comprehensive
review ofthe relationship between IQ and
earnings (45) andtheeffectson IQofmaternal
smoking during pregnancy (47). The impli-
cations are as follows:
* four million children born in 1994
* 20% of their mothers smoked during
pregnancy (800,000 children)
* offspring ofsmoking mothers average a
3% (3-point) drop in IQ
* assume 1 IQ point = $10,000 over a
workinglifetime ($250/year)
* multiplying 800,000 children by 3 =
2,400,000 lost IQpoints
* for the 1994 cohort, total loss = $24
million
* look back over 30 years (1964-1994)
with the samesmoking rates
* for 30 years, total earnings loss would be
$720 million (for a 30-year period, the
cumulative loss ofearnings greatly exceeds
the $200 billion proposed tobacco settle-
ment negotiated in November 1998 by
28 ofthe StateAttorneys General.
These calculations are based only on
projected income. Distributed across the off-
spring ofsmoking mothers, their sum is more
than twice the size ofthe tobacco settlement.
It does not include the costs ofother behav-
ioral disturbances associated with maternal
smoking such as conduct disorders (47). It
disregards cancer, emphysema, heart disease,
asthma, premature rupture ofmembranes in
pregnancy, low birthweight, and other costly
consequences oftobacco use.
Earnings are far from the sole index of
how reductions in population IQimpinge on
society. Herrnstein and Murray (48) pro-
posed the thesis that psychometric intelli-
gence, as measured by IQ, determines an
individual's position and success in society. It
further stoked a fierce debate that continues
unabated about the heritability ofIQand the
role ofrace. The empirical data upon which
the Herrnstein and Murray (48) analyses rely
come from the National Longitudinal Survey
ofYouth (49), a federal program operated by
the Department ofLabor to gather informa-
tion at multiple points in time on the labor
market experiences of five selected groups.
These data, independent ofany particular
stance on genetic contributions to IQ, are
depicted in Figure 8. They show that a rela-
tively small shift in IQ can produce substan-
tial effects on a number ofsocial indices.
Herrnstein and Murray (48) never
mentioned the contribution ofenvironmental
contaminants such as lead to IQscores. For
the environmental health sciences, the ironic
counterpoint is its implied message that deter-
mined efforts to reduce exposures to lead,
PCBs, and other developmental neurotoxi-
cants have inadvertently promoted social ben-
efits beyond our original expectations based
on improved health. We can also inspect the
mirror image ofthose data to calculate the
massive costs offailure to act on behalfof
environmental protectionforchildren.
We have only begun to grasp the breadth
ofchallenges that chemical contamination of
the environment poses to the developing
brain. Although we finally grasped the extent
ofhazards arising from lead exposure, we
became complacent about modern chemicals,
such as pesticides, because their contributions
to our lives were striking and transparent.
Their shortcomings proved elusive because
they were subtle enough not to be immedi-
ately apparent; moreover, we simply did not
understand how to ask the proper questions
about their toxicity. Recall the struggle to
document the dangers ofsmoking. Or the
astonishment provoked by Carson's Silent
Spring (50) and the attacks on hypotheses
advanced in Our Stolen Future (51). We cer-
tainly will discover new threats unforeseen by
our current knowledge that likely will take
the form ofan unraveling puzzle.
A provocative statement about lead from
the report by the Centers for Disease Control
(52) could serve as a guide. Ifthe references
to lead are left blank, the paragraph below
can be viewed as a terse description ofhow
our understanding of threats to neuro-
behavioral development tends to materialize.
[...] is ubiquitous in the human environ-
ment as a result ofindustrialization. It has
no known physiologic value. Children are
particularly susceptible to [...] toxic
effects. [...] poisoning, for the most part,
is silent: most poisoned children have no
symptoms. The vast majority ofcases,
therefore, go undiagnosed and untreated.
[...] poisoning is widespread. No socio-
economic group, geographic area, or racial
or ethnic population is spared.
Neurobehavioral toxicology is one ofthose
disciplines inextricably entangled with larger
issues and public policy. A superficially direct
index ofdevelopmental neurotoxicity such as
IQscore evokes broader questions such as how
it positions an individual in society, for
instance, and in the career and educational
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Figure 8. Societal benefits (i.e., reduction in certain
undesirable social factors)(48) of a 3% rise in 10, based
on National Longitudinal Survey of Youth data (49). The
Home score was based on the Home Observation for
Measurement ofthe Environment Inventory(53).
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opportunities it affords and in how it deter-
mines social class. Even more broadly, it awak-
ens questions about the structure ofsociety,
about its economic potential, and even about
the processes ofaging. The title ofthis paper
encompasses only the first step in our explo-
ration ofchildren's health and its implications.
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